Skip to main content

Table 1 Demographic and clinical characteristics of melasma - related reports collected from the FAERS database between January 2004 and June 2024

From: Melasma secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS)

Characteristics

Case number

Case proportion

Number of events

408

 

Sex

  

F

346

84.8%

M

35

8.6%

Missing

27

6.6%

Weight(kg)

  

<50

12

2.9%

>100

7

1.7%

50~100

123

30.1%

Missing

266

65.2%

Age(year)

  

18–35

96

23.5%

36–50

92

22.5%

51–65

26

6.4%

66–85

26

6.4%

Missing

168

41.2%

Reported Person

  

Consumer

216

52.9%

Health Professional

18

4.4%

Lawyer

4

1.0%

Physician

78

19.1%

Other health-professional

41

10.0%

Pharmacist

12

2.9%

Missing

39

9.6%

Reported Countries (top five)

  

United States

234

57.4%

United Kiongdom

23

5.6%

France

19

4.7%

Brazil

14

3.4%

Italy

9

2.2%

Outcome

  

Death

2

0.5%

Life-Threatening

4

1.0%

Hospitalization

41

10.0%

Disability

15

3.7%

Other Serious

116

28.4%

Missing

227

55.6%

Indications (top five)

  

Contraception

110

27.0%

Acne

8

2.0%

Breast cancer

8

2.0%

Multiple sclerosis

8

2.0%

Rheumatoid arthritis

7

1.7%